Appendix III: Scope of Service of CUHK Service Units

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Drug design and testing,. Drug Names Chemical name- describes its molecular structure and distinguishes it from other drugs.
Producing a Pharmaceutical or Biopharmaceutical
Translational Medicine Turning Basic Research into Medicines and Treatments.
Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan.
Protein Therapeutics: a summary and pharmacological classification
Biopharmaceutical Production Biopharmaceutical development and GMP manufacturing Professionally sound Reliable Innovative Open Respectful.
Stages of drug development
Drug discovery and development
Akadeemia tee 21 Tallinn Estonia Reg.nr.: InBio Ltd. ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS.
Biotechnology Products & Regulatory requirements Medical Writer Group NL Naarden, 8 Dec 2005 H.F. Schuring.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Ensuring Product Quality in Gene Transfer Clinical Trials
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
Biotechnology and Medicine Esmaeil Sadroddiny, PhD Medical Biotechnology.
A 1 Smallpox Vaccine Downselection National Vaccine Advisory Committee February 4, 2003.
Lecture 38 Plantibodies.
Topics discussed in the presentation
Akadeemia tee 21 Tallinn Estonia Reg.nr.: InBio Ltd. ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS.
FLEXGene Repository Applications. Exploiting FLEXGene Genes FLEXGene Clones Expression Clones Proteins Protein Expression Localization Interaction Functional.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Intellectual Property Rights and Pharmaceutical Industry
Implementation of the CTD: CBER’S Perspective May 8, 2001 Joan Wilmarth Blair, M.A. International Affairs Advisor CBER/FDA May 8, 2001 Joan Wilmarth Blair,
Gene Therapy Clinical Trials. Cancer Gene Therapy Three Basic Approaches. Genetically alter a person's immune cells that are already naturally targeted.
WHAT IS A BIOSIMILAR? Philip D. Home, DM, DPhil Professor of Diabetes Medicine Newcastle University Consultant Diabetologist Newcastle Diabetes Centre.
Figure 1.1. Industry Value Chain Problem to be solved Technology innovation Basic research Applied research Pilot phase (Prod dev) Application phase (Production)
The GS Gene Expression System™
Structures and functions of biomolecules & applications Purin Charoensuksai, PhD Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University.
E-Clinical
University College London C hemical Engineering Exchange Program Biochemical Engineering Exchange Program ISU Coordinator: C. Glatz, 2162b Sweeney.
Shows tendency for mergers. These big companies may be shrinking – much research is now outsourced to low cost countries like Latvia, India, China and.
httpwww.youtube.com/watch?v=DhxD6sVQEYc:// The Drug Discovery Process.
The process of drug development. Drug development 0,8 – 1 mld. USD.
Drug discovery involves systematically identifying which protein is causing a problem in the body - either because it is absent, defective, or excessive.
 Therapeutic or preventive medicine derived from living cells using recombinant DNA technology  Conventional pharmaceuticals are generally small molecules.
DESIGNING A MULTIPRODUCT PLANT FOR RECOMBINANT BIOPHARMACEUTICALS. MAJOR CONSIDERATIONS Biotec India International, 2003.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
APPLICATIONS OF ANIMAL CELL CULTURE
Pharmaceutical Biotechnology
Page 1 Stable Cell Line Construction for Protein Expression —P rofacgenP rofacgen.
Department of Zoology, R.U.
VxP Biologics The Biologics Service Company
BSB Biomanufacturing CHAPTER 5 Upstream Processes
Producing a Pharmaceutical or Biopharmaceutical
3P Biopharmaceuticals 3P Biopharmaceuticals is a European-based Contract Development and Manufacturing Organization (CDMO) specialized in the process development.
Introduction and Definitions
Monoclonal antibody production
Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.
Biotechnology Objectives: At the end of this lecture we will be able to identify and describe the uses of biotechnology in society.
PREFORMULATION Important stages where Preformulation, Biopharmaceutics and Formulation plays a key role are – Candidate drug selection Various stages of.
The Lifecycle of Pharmaceutical products
Market and R&D Analysis of Recombinant Protein Drugs.
סמים וסינפסות.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
Therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer a.
Biosimilar monoclonal antibodies Biologics are critical components in the treatment of patients with cancer. Biosimilars - biologics that are highly similar.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
Drug design and testing,
? Neutralizing Antibodies: Research pathways in 2013 and beyond
PREDICT.
The increasing availability of quantitative biological data from the human genome project, coupled with advances in instrumentation, reagents, methodologies,
Drug Design and Drug Discovery
Promega Corporation: Technology Areas of Interest
Producing a Pharmaceutical or Biopharmaceutical
Producing a Pharmaceutical or Biopharmaceutical
VICH Guidelines on stability: OVERVIEW
The Systematic Production of Cells for Cell Therapies
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
VICH Guidelines on stability: OVERVIEW
Presentation transcript:

Appendix III: Scope of Service of CUHK Service Units Drug Class Further Sub-class Drug Discovery Dosage Formulation Physical, Chemical or Biochemical Characterization Process Development Clinical Trial Production Clinical Trial Regulatory & Consultancy Construction of Production Plant Commercial Production Product Registration TCM Formulation development, stability test, in vivo ADME/T Design, engineering consultation, Validation Documentation, Plant Integrity Testing Chemical Drugs In-vitro ADME/T Formulation, stability, in vivo ADME/T Characterization & Assay development Phase I & II Phase III Biologics Biopharmaceuticals Cell Banking Cell Line Characterization Gene Cloning Protein Characterization Process Scale-up, Process Improvement, Purification, Process Validation / Evaluation Monoclonal Antibodies Recombinant Proteins Fermentation products of TCM origin Vaccine Blood Products Generics BA / BE Legend: HKIB DDC Centre for Clinical Trial CUCAMed HKIB additional targeted area

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.